This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of. Active years: 1994-1999.
Location History:
- Gaithersburg, MD (US) (1994)
- Rockville, MD (US) (1997 - 1999)
Company Filing History:
3 out of 1,217 
1 out of 2,202 
Years Active: 1994-1999
Title: Maqbool A Siddiqui: Innovator in Nucleoside Analogues
Introduction
Maqbool A Siddiqui is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of nucleoside analogues, holding a total of 4 patents. His work focuses on developing compounds that have therapeutic applications, particularly in treating viral infections.
Latest Patents
Siddiqui's latest patents include innovative methods for creating conformationally locked nucleoside analogues. One of his patents details the preparation of conformationally locked 4',6'-cyclopropane-fused carboxylic nucleoside analogues. These compounds are synthesized by condensing a cyclopropane-fused carbocyclic allylic alcohol with substituted purine or pyrimidine bases. The resulting condensation products are modified to yield adenosine, guanosine, cytidine, thymidine, and uracil nucleoside analogues. These compounds are recognized for their therapeutic usefulness as antimetabolites and in the development of anti-metabolic agents.
Another significant patent involves the use of conformationally locked nucleoside analogs as antiherpetic agents. This method provides a treatment for herpes virus infections by administering a cyclopropanated carbocyclic 2'-deoxynucleoside in an effective virus-inhibiting amount. The nucleoside analogs have shown efficacy against herpes simplex virus types 1 and 2, Epstein-Barr Virus, and human cytomegalovirus.
Career Highlights
Throughout his career, Siddiqui has worked with esteemed organizations, including the United States of America as Represented by the Department of Health and the United States of America as Represented by the Secretary of Health. His work has significantly impacted the field of virology and therapeutic development.
Collaborations
Siddiqui has collaborated with notable colleagues such as Victor E Marquez and Marc C Nicklaus. Their combined expertise has contributed to the advancement of research in nucleoside analogues.
Conclusion
Maqbool A Siddiqui's innovative work in the development of nucleoside analogues has paved the way for new therapeutic approaches in treating viral infections. His contributions to science and medicine continue to be recognized and valued.